Showing results (11-20 of 1,875) with videos related to
Sort By:
Pageof 188
Therapeutic Advances in Medical Oncology|July 15, 2021
Targeted therapy in SDH-deficient GISTMargherita Nannini, Alessandro Rizzo, Valentina Indio, et al.Therapeutic Advances in Medical Oncology|July 15, 2021
Largely varying patterns and trends of primary cancer-directed resection for gastric carcinoma with synchronous distant metastasis in Europe and the US: a population-based study calling for further standardization of careLei Huang, Lina Jansen, Rob H A Verhoeven, et al.Therapeutic Advances in Medical Oncology|May 28, 2021
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)Sara Elena Rebuzzi, Alessio Signori, Giuseppe Luigi Banna, et al.Therapeutic Advances in Medical Oncology|November 21, 2022
Adjunctive PD-1 inhibitor versus standard chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysisEdgar Theodore Polintan, Stephanie Krystel Canicula, Jesus Alfonso Catahay, et al.Therapeutic Advances in Medical Oncology|June 23, 2021
Phase I study of pucotenlimab (HX008), an anti-PD-1 antibody, for patients with advanced solid tumorsRujiao Liu, Wenhua Li, Yanchun Meng, et al.Therapeutic Advances in Medical Oncology|January 5, 2023
Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective studyLeandro Jonata Carvalho Oliveira, Thais Baccili Cury Megid, Daniela Dornelles Rosa, et al.Therapeutic Advances in Medical Oncology|January 16, 2023
Disparity in the era of personalized medicine for epithelial ovarian cancerMichael-John Devlin, Rowan E MillerTherapeutic Advances in Medical Oncology|January 16, 2023
The postoperative prognosis of skip-N2 metastasis is favorable in small-cell lung carcinoma patients with pathological N2 classification: a propensity-score-adjusted retrospective multicenter studyLei-Lei Wu, Shen-Hua Liang, Feng Jiang, et al.Therapeutic Advances in Medical Oncology|January 16, 2023
Renal impairment and abnormal liver function tests in pre-therapeutic phenotype-based DPD deficiency screening using uracilemia: a comprehensive population-based study in 1138 patientsSidonie Callon, Mathias Brugel, Damien Botsen, et al.Therapeutic Advances in Medical Oncology|January 16, 2023
The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapyHaoran E, Junqi Wu, Yijiu Ren, et al.Pageof 188